Resultados de la búsqueda 1191-1200 of 10807 for preventionintroduction

  1. Oncología (médica) - Ensayos clínicos

    The collected tissue specimens will be used to develop preclinical models; i.e., cell lines, patient derived micro-cancer models as well as patient-derived ...

  2. Oncología (médica) - Ensayos clínicos

    This open-label, exploratory study is designed to evaluate the safety and efficacy of targeted therapies or immunotherapy as single agents or combinations, in ...

  3. Oncología (médica) - Ensayos clínicos

    A side effect is anything a drug does to the body besides treating your disease. Participants in this study have colorectal cancer that has spread through the ...

  4. Sarna - Diagnóstico y tratamiento - Mayo Clinic

    Centers for Disease Control and Prevention. https://www.cdc.gov/parasites/scabies. Accessed April 8, 2022. Relacionado. Sarna. Productos y servicios. Mayo ...

  5. Oncología (médica) - Ensayos clínicos

    The purpose of this long term registry study is to collect and analyze information from patients being treated with various forms of radiation therapy to ...

  6. Cirugía de la base del cráneo endoscópica - Mayo Clinic

    Atención médica en Mayo Clinic. Atención médica centrada en el paciente · Información sobre Mayo Clinic · Pedir una cita · Encuentra un médico.

  7. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to compare the effects, good and/or bad of two treatment methods on subjects and their cancer. Proton beam radiation therapy is ...

  8. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to determine the safety and tolerability of personalized neoantigen peptide administered in combination with pembrolizumab to ...

  9. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to evaluate the safety and effectiveness of nonconforming idecabtagene vicleucel (ide-cel) in subjects with multiple myeloma per ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...